Literature DB >> 24138599

The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes.

Pjotr Bekkering1, Ismael Jafri, Frans J van Overveld, Ger T Rijkers.   

Abstract

It has been proposed that changes in the composition of gut microbiota contribute to the development of diabetes Types 1, 2 and 3 (the latter known as Alzheimer's disease). The onset of these diseases is affected by complex interactions of genetic and several environmental factors. Alterations in gut microbiota in combination with specific diets can result in increased intestinal permeability leading via a continuous state of low-grade inflammation to the development of insulin resistance. Since a change in composition of gut microbiota is also suggested to be the underlying factor for the development of obesity, it is obvious to link gut microbiota with the pathogenesis of diabetes. In addition, insulin resistance in the brain has been recently associated with Alzheimer's disease. These new paradigms in combination with data from studies with prebiotics and probiotics may lead to a novel way to control and even prevent diabetes in general.

Entities:  

Mesh:

Year:  2013        PMID: 24138599     DOI: 10.1586/1744666X.2013.848793

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  25 in total

Review 1.  Type 1 diabetes and gut microbiota: Friend or foe?

Authors:  Changyun Hu; F Susan Wong; Li Wen
Journal:  Pharmacol Res       Date:  2015-03-05       Impact factor: 7.658

Review 2.  The sex-specific interaction of the microbiome in neurodegenerative diseases.

Authors:  Laura M Cox; Hadi Abou-El-Hassan; Amir Hadi Maghzi; Julia Vincentini; Howard L Weiner
Journal:  Brain Res       Date:  2019-08-13       Impact factor: 3.252

Review 3.  The microbiome and systemic lupus erythematosus.

Authors:  Nurit Katz-Agranov; Gisele Zandman-Goddard
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

Review 4.  Role of the gastrointestinal ecosystem in the development of type 1 diabetes.

Authors:  Joseph G Daft; Robin G Lorenz
Journal:  Pediatr Diabetes       Date:  2015-05-08       Impact factor: 4.866

Review 5.  Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.

Authors:  Susan Westfall; Nikita Lomis; Imen Kahouli; Si Yuan Dia; Surya Pratap Singh; Satya Prakash
Journal:  Cell Mol Life Sci       Date:  2017-06-22       Impact factor: 9.261

Review 6.  The Role of Nutritional Factors in the Modulation of the Composition of the Gut Microbiota in People with Autoimmune Diabetes.

Authors:  Anna Winiarska-Mieczan; Ewa Tomaszewska; Janine Donaldson; Karolina Jachimowicz
Journal:  Nutrients       Date:  2022-06-16       Impact factor: 6.706

Review 7.  Can functional oligosaccharides reduce the risk of diabetes mellitus?

Authors:  Di Zhu; Qiaojuan Yan; Jun Liu; Xia Wu; Zhengqiang Jiang
Journal:  FASEB J       Date:  2019-08-15       Impact factor: 5.834

8.  Role of Corticotropin-releasing Factor in Gastrointestinal Permeability.

Authors:  Bruno K Rodiño-Janeiro; Carmen Alonso-Cotoner; Marc Pigrau; Beatriz Lobo; María Vicario; Javier Santos
Journal:  J Neurogastroenterol Motil       Date:  2015-01-01       Impact factor: 4.924

9.  Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized, double-blind, clinical trial.

Authors:  Zarin Sadat Ebrahimi; Ensieh Nasli-Esfahani; Azadeh Nadjarzade; Hassan Mozaffari-Khosravi
Journal:  J Diabetes Metab Disord       Date:  2017-06-02

Review 10.  Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis.

Authors:  Trisha A Jenkins; Jason C D Nguyen; Kate E Polglaze; Paul P Bertrand
Journal:  Nutrients       Date:  2016-01-20       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.